RECOVERY-Enchancing Cancer Registry Data for Comparative Effectiveness

RECOVERY - Task Order Notification THIS NOTICE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY UNDER THE AMERICAN RECOVERY AND REINVESTMENT ACT (ARRA). This opportunity is available only for competition among the Centers for Disease Control and Prevention (CDC) Indefinite Delivery Indefinite Quantity(IDIQ) awardees from solicitation 2008-N-09699. The awardees were: ABT (200-2008-27954), Battelle (200-2008-27956), Macro 200-2008-27957), RTI (200-2008-27958), SAIC (200-2008-27959), and Westat (200-2008-27960). Project Title: ARRA OS Enhancing cancer registry data for comparative effectiveness. The purpose of this task order is to conduct activities to establish Specialized Cancer Registries to enhance data collected through a subset of population based central cancer registries for comparative effectiveness research. Activities include data collection, methodological development and pilot testing activities with the goal of enhancing cancer registry data for clinical follow-up. Outcomes will include a data set to be used for comparative effectiveness and other research. This data set will provide a unique set of data items in a single data set. Data from these funded activities will be made available for researchers through an established National Center for Health Statistics Research Data Center (RDC). The use of the RDC will allow CDC to protect the data as required by state laws authorizing the collection of cancer diagnoses and treatment data and CDC's Assurance of Confidentiality; and protect the confidentiality of patients whose data are included in the data set. It is anticipated that updates to the data will also be available through the RDC. American Recovery and Reinvestment Act (ARRA) terms, conditions and reporting will be applicable to the work under this project. This is not a request for competitive proposals, nor is a solicitation available. Period of Performance: The work shall be from date of award through 9/30/2013. Any questions regarding this notice must be submitted in writing to Maryann Schlemmer at [email protected]